89bio to Participate in the 2023 Cantor Global Healthcare Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SAN FRANCISCO, Sept. 20, 2023 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, today announced that the Company’s Management will participate in a fireside chat and one-on-one investor meetings at the 2023 Cantor Global Healthcare Conference, being held in New York, NY on Tuesday, September 26, 2023 at 11:40 AM ET.

The webcast of the fireside chat will be accessible here and in the investor section of 89bio’s website.

About 89bio 
89bio is a clinical-stage biopharmaceutical company dedicated to the development of best-in-class therapies for patients with liver and cardiometabolic diseases who lack optimal treatment options. The company is focused on rapidly advancing its lead candidate, pegozafermin, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). Pegozafermin is a specifically engineered, potentially best-in-class fibroblast growth factor 21 (FGF21) analog with unique glycoPEGylated technology that optimizes biological activity through an extended half-life. The company is headquartered in San Francisco. For more information, visit www.89bio.com or follow the company on LinkedIn.

Investor Contact: 
Annie Chang 
89bio
annie.chang@89bio.com

PJ Kelleher
LifeSci Advisors, LLC
+1-617-430-7579
pkelleher@lifesciadvisors.com

Media Contact: 
Sheryl Seapy
Real Chemistry
sseapy@realchemistry.com

Staff

Recent Posts

Santiam Hospital and Clinics enters into Prime Vendor agreement with Medline

Oregon-based hospital taps into Medline's custom pack capabilities and distribution services NORTHFIELD Ill., June 9,…

6 hours ago

20/20NOW Advances Tele-Optometry with New VP of Professional Services Dr. Noelle Tchang OD and Spotlights Telehealth at Digital EyeCon

HOLBROOK, N.Y., June 9, 2025 /PRNewswire/ -- 20/20NOW, a pioneer in ocular telehealth, proudly announces…

6 hours ago

Business Integra Launches Mission-Ready Healthcare Staffing Solutions Backed by AI Technology

BETHESDA, Md., June 9, 2025 /PRNewswire/ -- Business Integra (BI), a leader in mission-critical talent solutions,…

6 hours ago

Imre Introduces the AI Conversation Converter

Agency launches First-in-Kind platform to quickly insert healthcare brands directly into the AI conversation NEW…

6 hours ago

Health-E Commerce® expands telehealth offerings with LifeMD™ to provide sleep treatments via FSA Store® and HSA Store®

New collaboration delivers 50% off prescription sleep support for new customers who are struggling with…

12 hours ago